The Journal of Global Drug Policy and Practice is an international journal with the goal of bridging the information gap on drug policy issues between the medical-scientific community, policymakers, practitioners and the lay public. Our intended readership includes clinicians, clinical researchers, policymakers, prevention specialists and other persons interested in understanding drug policy issues or in providing drug policy recommendations. The Journal of Global Drug Policy and Practice is a joint effort of the Institute on Global Drug Policy and the International Scientific and Medical Forum on Drug Abuse.

Our Editorial Board consists of respected professionals in drug policy, practice and substance abuse prevention.

Ernst Aeschbach, MD
Andrea G. Barthwell, MD, FASAM
Robert DuPont, MD, Institute for Behavior and Health
David G. Evans, Esq., Drug Free Schools Coalition
Calvina Fay, MBA, Executive Director, Drug Free America Foundation
Jack Gilligan, PhD, Fayette Companies
David A. Gross, MD, DFAPA
Edward A. Jacobs, MD, Everett Clinic
William S. Jacobs, MD, University of Florida
Mel Levitsky, University of Michigan
Ian Oliver, PhD, UNODC
Robert E. Peterson, Esq., PRIDE Youth Programs, International
Herbert Schaepe, MD
Richard Schwartz, MD, Inova Hospital for Children
Peter Stoker, C. Eng., MICE (Retd.), Director, National Drug Prevention Alliance
Eric A. Voth, MD, FACP

Contact us to receive email updates on upcoming issues.

This project was supported by Grant No. 2005-JL-FX-0128 awarded by the Office of Juvenile Justice and Delinquency Prevention, Office of Justice Programs, U.S. Department of Justice. Points of view or opinions on this website are those of the author and do not necessarily represent the official position or policies of the U.S. Department of Justice.